Article: Case Report: First attempt by off-label use of tenecteplase to treat acute extensive portal venous system thrombosis.
Frontiers in cardiovascular medicine
2024 Volume 11, Page(s) 1342529
Abstract: Acute extensive portal venous system thrombosis (PVST) can cause lethal complications. Herein, we have for the first time reported the use of anticoagulation combined with systemic thrombolysis by tenecteplase in a male patient with a diagnosis of acute ... ...
Abstract | Acute extensive portal venous system thrombosis (PVST) can cause lethal complications. Herein, we have for the first time reported the use of anticoagulation combined with systemic thrombolysis by tenecteplase in a male patient with a diagnosis of acute extensive PVST but without liver cirrhosis. After thrombolytic therapy, abdominal pain obviously alleviated. However, urinary bleeding developed, which was reversible by stopping thrombolytic drugs. Finally, this case developed cavernous transformation of the portal vein without portal venous recanalization. In future, the efficacy and safety of tenecteplase should be explored in acute extensive PVST cases. |
---|---|
Language | English |
Publishing date | 2024-02-22 |
Publishing country | Switzerland |
Document type | Case Reports |
ZDB-ID | 2781496-8 |
ISSN | 2297-055X |
ISSN | 2297-055X |
DOI | 10.3389/fcvm.2024.1342529 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.